
Lorri Jones
Global Commercialization Strategist
Bio:
A passionate and innovative commercial leader, Lorri has her finger firmly on the pulse of global commercialization, innovation and customer engagement. She has built, launched and revitalized brands in complex, dynamic environments as a leader at Novartis, Pfizer, Astellas, and Shire. She brings strategic insights into value creation-from early-stage innovation to successful market entry and sunsetting assets.
A trusted thought partner and strategic advisor, Lorri has played a critical role in due diligence assessments for multi-billion-dollar acquisitions, and for integrations and divestitures of assets and companies. Her leadership has driven the successful commercialization of assets in ophthalmology, neuroscience, endocrinology, women’s health, nephrology, rare diseases and allogeneic cell therapies. Known for her ability to unite and inspire cross-functional teams, she navigates diverse global markets including US, Europe, UK, Japan, China, India and Russia with cultural intelligence and precision.
Warm, insightful, and forward‑thinking, Lorri blends global perspective with deep brand expertise, making her a compelling and trusted voice in today’s rapidly evolving healthcare landscape.